| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Ramesh Aparna | EVP - Chief Financial Officer | C/O FARMER MAC, 2100 PENNSYLVANIA AVE., NW, SUITE 450N, WASHINGTON | Jonathan Cohen, as attorney-in-fact for Aparna Ramesh | 13 Jun 2025 | 0001799715 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AGM | Class C Non-Voting Common Stock | Options Exercise | $105,453 | +876 | +8.4% | $120.38 | 11,264 | 11 Jun 2025 | Direct | F1, F2, F3 |
| transaction | AGM | Class C Non-Voting Common Stock | Tax liability | $31,855 | -163 | -1.4% | $195.43 | 11,101 | 11 Jun 2025 | Direct | F1, F2, F3 |
| transaction | AGM | Class C Non-Voting Common Stock | Disposed to Issuer | $105,532 | -540 | -4.9% | $195.43 | 10,561 | 11 Jun 2025 | Direct | F1, F2, F3 |
| transaction | AGM | Class C Non-Voting Common Stock | Options Exercise | $202,259 | +1,496 | +14% | $135.20 | 12,057 | 11 Jun 2025 | Direct | F2, F3, F4 |
| transaction | AGM | Class C Non-Voting Common Stock | Tax liability | $43,581 | -223 | -1.8% | $195.43 | 11,834 | 11 Jun 2025 | Direct | F2, F3, F4 |
| transaction | AGM | Class C Non-Voting Common Stock | Disposed to Issuer | $202,270 | -1,035 | -8.7% | $195.43 | 10,799 | 11 Jun 2025 | Direct | F2, F3, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AGM | Stock Appreciation Right | Options Exercise | $0 | -876 | -100% | $0.000000 | 0 | 11 Jun 2025 | Class C Non-Voting Common Stock | 876 | $120.38 | Direct | F1, F2 |
| transaction | AGM | Stock Appreciation Right | Options Exercise | $0 | -1,496 | -67% | $0.000000 | 748 | 11 Jun 2025 | Class C Non-Voting Common Stock | 1,496 | $135.20 | Direct | F2, F4, F5 |
| Id | Content |
|---|---|
| F1 | In connection with the net share settlement of the exercise of 876 vested stock appreciation rights ("SARs") granted in March 2022 with a grant price of $120.38 per share, Ms. Ramesh was entitled to receive 336 shares of Class C Non-Voting Common Stock of the Federal Agricultural Mortgage Corporation ("Farmer Mac"). Of these shares, Ms. Ramesh received 173 shares, and Farmer Mac retained 163 shares to satisfy tax withholding requirements arising from the exercise. The 540 shares reported as a disposition to the issuer of issuer equity securities represents the difference between the number of SARs exercised and the number of shares issuable as a result of the exercise. Each SAR represents the right to receive, upon exercise, the number of shares of Farmer Mac's Class C Non-Voting Common Stock equal to the excess of the fair market value of shares on the exercise date over the grant price. |
| F2 | Transaction effected during an open trading window for employees and directors of Farmer Mac. |
| F3 | Includes 4,408 unvested restricted stock units previously granted pursuant to Farmer Mac's Amended and Restated 2008 Omnibus Incentive Pan, as described in more detail in the Reporting Person's prior filings under Section 16 of the Securities Exchange Act of 1934. |
| F4 | In connection with the net share settlement of the exercise of 1,496 vested SARs granted in March 2023 with a grant price of $135.20 per share, Ms. Ramesh was entitled to receive 461 shares of Class C Non-Voting Common Stock of Farmer Mac. Of these shares, Ms. Ramesh received 238 shares, and Farmer Mac retained 223 shares to satisfy tax withholding requirements arising from the exercise. The 1,035 shares reported as a disposition to the issuer of issuer equity securities represents the difference between the number of SARs exercised and the number of shares issuable as a result of the exercise. Each SAR represents the right to receive, upon exercise, the number of shares of Farmer Mac's Class C Non-Voting Common Stock equal to the excess of the fair market value of shares on the exercise date over the grant price. |
| F5 | Exercisable beginning March 31, 2024 with respect to 748 shares, beginning March 31, 2025 with respect to 748 shares, and beginning March 31, 2026 with respect to 748 shares. |